Target Price | €28.56 |
Price | €14.10 |
Potential |
102.55%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target M1 Kliniken 2026 .
The average M1 Kliniken target price is €28.56.
This is
102.55%
register free of charge
€29.40
108.51%
register free of charge
€23.74
68.33%
register free of charge
|
|
A rating was issued by 8 analysts: 7 Analysts recommend M1 Kliniken to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the M1 Kliniken stock has an average upside potential 2026 of
102.55%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million € | 339.18 | 364.21 |
7.23% | 7.38% | |
EBITDA Margin | 9.33% | 9.41% |
48.98% | 0.91% | |
Net Margin | 4.72% | 4.78% |
45.48% | 1.20% |
5 Analysts have issued a sales forecast M1 Kliniken 2025 . The average M1 Kliniken sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an M1 Kliniken EBITDA forecast 2025. The average M1 Kliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 M1 Kliniken Analysts have issued a net profit forecast 2025. The average M1 Kliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 0.82 | 0.93 |
57.69% | 13.41% | |
P/E | 15.22 | |
EV/Sales | 0.65 |
5 Analysts have issued a M1 Kliniken forecast for earnings per share. The average M1 Kliniken EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 08 2025 |
WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Jun 29 2025 |
HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Jun 06 2025 |
Analyst Rating | Date |
---|---|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Sep 15 2025 |
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Sep 03 2025 |
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 09 2025 |
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 08 2025 |
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Jun 30 2025 |
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Jun 29 2025 |
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Jun 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.